SFX by Ex Libris Inc.

Title:	Common variations in BARD1 influence susceptibility to high-risk neuroblastoma
Source:	Nature Genetics [1061-4036] Capasso, Mario yr:2009

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Kai Wang; Sharon J. Diskin; Haitao Zhang; Edward F. Attiyeh; Cynthia Winter; Cuiping Hou; Robert W. Schnepp; Maura Diamond; Kristopher Bosse; Patrick A. Mayes; Joseph Glessner; Cecilia Kim; Edward Fra, Sharon i. "Integrative genomics identifies LMO1 as a neuroblastoma oncogene." Nature 469.7329 (2011): 216-220.
description	2.	Capasso, M. "Replication of GWAS-identified neuroblastoma risk loci strengthens the role of BARD1 and affirms the cumulative effect of genetic variations on disease susceptibility." Carcinogenesis 34.3 (2013): 605-11.
description	3.	Swanton, C. "Molecular classification of solid tumours: towards pathway-driven therapeutics." The British Journal of Cancer 100.10 (2009): 1517-1522.
description	4.	Casalunovo, C. "Chromosome 6p22 locus associated with clinically aggressive neuroblastoma." New England Journal of Medicine, The 358.24 (2008): 2585-93.
description	5.	Maris, John M. "Recent advances in neuroblastoma." New England Journal of Medicine, The 362.23 (2010): 2202-2211.
description	6.	Carén,, Helena, H. "High-risk neuroblastoma tumors with 11 q-deletion display a poor prognostic, chromosome instability phenotype with later onset." Proceedings of the National Academy of Sciences of the United States of America 107.9 (2010): 4323-4328.
description	7.	Diskin, Sharon J. "Rare Variants in TP53 and Susceptibility to Neuroblastoma." Journal of the National Cancer Institute 106.4 (2014).
description	8.	Chen, C. "Recent players in the field of acute myocardial infarction biomarkers: Circulating cell-free DNA or microRNAs?" International journal of cardiology 168.3 (2013): 2956-2957.
description	9.	Nguyen, Le B. "Phenotype restricted genome-wide association study using a gene-centric approach identifies three low-risk neuroblastoma susceptibility Loci." PLOS Genetics 7.3 (2011).
description	10.	Udayakumar, D. "Epha2 is a critical oncogene in melanoma." Oncogene 30.50 (2011): 4921-9.
description	11.	Langfelder, P. "WGCNA: an R package for weighted correlation network analysis." BMC bioinformatics 9.1 (2008): 559-559.
description	12.	Castanotto, D. "The promises and pitfalls of RNA-interference-based therapeutics." Nature 457.7228 (2009): 426-433.
description	13.	Lee, Lee S. "MicroRNAs in Cancer." Annual review of pathology 4.1 (2008): 199-227.
description	14.	Woo, P. "Then and now: use of 16S rDNA gene sequencing for bacterial identification and discovery of novel bacteria in clinical microbiology laboratories." Clinical microbiology and infection 14.10 (2008): 908-934.
description	15.	Mossé, Andrew M. "Identification of ALK as a major familial neuroblastoma predisposition gene." Nature 455.7215 (2008): 930-935.
description	16.	Loose, M. "Global genetic regulatory networks controlling hematopoietic cell fates." Current opinion in hematology 13.4 (2006): 229-36.
description	17.	Golub, T R R. "Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring." Science 286.5439 (1999): 531-537.
description	18.	Lu, J. "MicroRNA expression profiles classify human cancers." Nature 435.7043 (2005): 834-838.
description	19.	Bishop, J M M. "Targeted expression of MYCN causes neuroblastoma in transgenic mice." The EMBO journal 16.11 (1997): 2985-95.
description	20.	Kushner, Nai-Kong V K. "Neuroblastoma--linking a common allele to a rare disease." New England Journal of Medicine, The 358.24 (2008): 2635-7.